Phaos Technology Holdings (Cayman) POAS
NYSE POAS
$0.16 +0.00 (+0.56%)
At close: Aug 20, 2026 · 2:25 PM UTC

Phaos Technology Holdings (Cayman) (POAS) Other Accumulated Expenses (2024 - 2025)

Phaos Technology Holdings (Cayman)'s (POAS) quarterly Other Accumulated Expenses came in at $2.9 million in Q4 2025, up 30.05% on a QoQ basis from $2.2 million in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Other Accumulated Expenses (2024 - 2025) Analysis & Trends

Phaos Technology Holdings (Cayman) (POAS) has 2 years of Other Accumulated Expenses data on file, last reported at $2.9 million in Q4 2025.

  • Quarterly Other Accumulated Expenses changed N/A year-over-year to $2.9 million in Q4 2025, while the trailing twelve-month figure through Oct 2025 was $2.9 million (changed N/A YoY) and the FY2025 annual result came in at $2.2 million, up 312.26% from the prior year.
  • Other Accumulated Expenses rose to $2.9 million in Q4 2025, from $2.2 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.9 million in Q4 2025 to a low of $544056.1 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn
10 Phaos Technology Holdings (Cayman) 4.23 Mn 4.19 Mn -

Historic Data

Download Data
DateValue
Oct 31, 2025 2.91 Mn
Apr 30, 2025 2.24 Mn
Apr 30, 2024 544,056.13